Compare JPMorgan Equity Premium Income ETF (JEPI) vs Nutrien Ltd (NTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Equity Premium Income ETF vs Nutrien Ltd — how do they compare? JPMorgan Equity Premium Income ETF trades at $56.6, while Nutrien Ltd trades at $67.14 (market cap $31.86B). The key difference: Nutrien Ltd pays a 3.27% dividend while JPMorgan Equity Premium Income ETF pays none, and Nutrien Ltd is trading nearer its 52-week high, JPMorgan Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| JEPI | NTR | |
|---|---|---|
Sector | Income / Options Overlay | Basic Materials |
52-Week High | $59.88 | $83.94 |
52-Week Low | $55.29 | $53.64 |
Market Cap | — | $31.86B |
Enterprise Value | — | $45.03B |
Dividend Yield | — | 3.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JEPI, the JPMorgan Equity Premium Income ETF, trades at $56.55, down 0.75% on the day. The technical outlook is bullish based on moving averages, though oscillators are neutral. Recent news highlights a focus on its high yield and monthly income strategy, but also raises concerns about underperformance versus the S&P 500 and tax inefficiency in taxable accounts, framing a debate between income generation and total return.
The outlook centers on JEPI's role as an income vehicle in a diversified portfolio. The primary opportunity is its high, option-premium-driven yield in a low-volatility environment. Key risks include capped upside during strong bull markets, potential tracking error from its synthetic call strategy, and significant tax implications for holders in non-retirement accounts.
Nutrien (NTR) trades at $67.28, up 0.27% with a bullish technical signal supported by moving averages. The company shows improving fundamentals with Q1 2026 EPS beating expectations and revenue growth projected to $27.8B in 2026. Valuation metrics appear reasonable with P/E of 13.7 and P/S of 1.17. Recent news highlights strong fertilizer demand and upcoming Q2 2026 earnings release on August 5.
NTR presents a favorable risk-reward profile with analyst consensus target of $77.67 representing 15% upside. The stock benefits from healthy fertilizer demand and cost controls, though faces headwinds from volatile input costs and global supply chain pressures. Institutional sentiment remains positive with 61% buy ratings supporting the bullish case.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →
